Khoo Su Pei, Bouniu Joanne Johnny, Sivaram Lavanya, Hawkes David, Tan Peng Chiong, Saville Marion, Woo Yin Ling
Department of Obstetrics and Gynaecology, University of Malaya Medical Centre, Kuala Lumpur, Malaysia.
Australian Centre for the Prevention of Cervical Cancer, Carlton, Victoria, Australia.
PLOS Glob Public Health. 2025 Sep 2;5(9):e0005149. doi: 10.1371/journal.pgph.0005149. eCollection 2025.
This study evaluated the feasibility, safety, and acceptability of self-collected vaginal samples for human papillomavirus (HPV) testing among pregnant women in an urban teaching hospital in Malaysia. This cross-sectional study recruited pregnant women aged 30 years and above who attended antenatal care at the University of Malaya Medical Centre. Participants self-collected vaginal samples using FLOQSwabs and completed pre- and post-sampling questionnaires assessing acceptability. Samples were analysed using the Roche cobas 4800 system. HPV-positive participants were referred for postpartum colposcopy. A total of 2,256 eligible pregnant women were invited to participate in the study and 1,603 of them consented to participate, representing 71.1% of uptake. Of the 1,603 participants, 99.6% (1,596) agreed to self-collect, with 98.6% successfully completing the procedure. More than 80% of participants responded positively to acceptability indicators after self-collection procedure, including overall feeling, ease of performance, convenience, and confidence in collecting an accurate sample. The HPV prevalence recorded in the study population was 6.3%, with most infections involving non-HPV16/18 types. No major complications associated with the sampling procedure were reported, and 99.0% of participants expressed willingness to use self-collection for future cervical screening. Self-collection for HPV-based cervical screening during pregnancy is highly acceptable, safe, and feasible, with performance comparable to the general population. Integrating self-collection into antenatal care can enhance cervical cancer screening rates among under-screened populations, contributing to global elimination goals.
本研究评估了在马来西亚一家城市教学医院中,孕妇自行采集阴道样本进行人乳头瘤病毒(HPV)检测的可行性、安全性和可接受性。这项横断面研究招募了年龄在30岁及以上、在马来亚大学医学中心接受产前护理的孕妇。参与者使用FLOQSwabs自行采集阴道样本,并完成采样前后评估可接受性的问卷。样本使用罗氏cobas 4800系统进行分析。HPV检测呈阳性的参与者被转诊进行产后阴道镜检查。共有2256名符合条件的孕妇被邀请参与研究,其中1603人同意参与,参与率为71.1%。在1603名参与者中,99.6%(1596人)同意自行采集样本,其中98.6%成功完成了该操作。超过80%的参与者在自行采集样本后对可接受性指标给出了积极回应,包括总体感受、操作难易程度、便利性以及对采集准确样本的信心。研究人群中记录的HPV感染率为6.3%,大多数感染涉及非HPV16/18型。未报告与采样程序相关的重大并发症,99.0%的参与者表示愿意在未来的宫颈癌筛查中使用自行采集样本的方式。孕期基于HPV的宫颈癌筛查自行采集样本的方式是高度可接受、安全且可行的,其表现与普通人群相当。将自行采集样本纳入产前护理可以提高筛查不足人群的宫颈癌筛查率,有助于实现全球消除宫颈癌的目标。